SMYD2 and acute myeloid leukemia: However, downregulation of SET7/9 through hypermethylation of the SET7/9 promoter was also observed in AML patient cells, and further studies are required to identify the target mechanism underlying the regulation of SMYD2 and SET7/9 [158].